SCHEMBL8796237

SCHEMBL8796237

CCOC(=O)c1cccc(/C(=C/c2ccc3c(c2)C(C)(C)CCC3(C)C)CO[Si](C)(C)C(C)(C)C)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARA P10276 10/20 0.41
RARB P10826 9/20 0.41
RARG P13631 9/20 0.41
RXRA P19793 5/20 0.39
NPC1 O15118 3/20 0.35
RAB9A P51151 3/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
CYP1A2 P05177 2/20 0.35
CYP2C19 P33261 2/20 0.35
KDM4E B2RXH2 2/20 0.35
ALDH1A1 P00352 2/20 0.35
LMNA P02545 2/20 0.35
POLB P06746 2/20 0.35
CYP26A1 O43174 1/20 0.35
GMNN O75496 1/20 0.35
USP2 O75604 1/20 0.35
TP53 P04637 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
NFKB1 P19838 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8796246 1.00 RARA (0.41) RARARARBRARGRXRANPC1
SCHEMBL8796891 0.92 PLA2G4A (0.45) RARARARBRARGNPC1RAB9A
SCHEMBL8796886 0.92 PLA2G4A (0.45) RARARARBRARGNPC1RAB9A
SCHEMBL8796493 0.86 RARG (0.38) RARARARBRARGRXRANPC1
SCHEMBL8796491 0.86 RARG (0.38) RARARARBRARGRXRANPC1
SCHEMBL8796453 0.86 RARA (0.41) RARARARBRARGRXRANPC1
SCHEMBL8796470 0.84 RARB (0.46) RARARARBRARGRXRANPC1
SCHEMBL8796047 0.84 RARB (0.46) RARARARBRARGRXRANPC1
SCHEMBL8795222 0.83 KMT2A (0.44) NPC1RAB9ASMN1; SMN2CYP1A2CYP2C19
SCHEMBL8795499 0.83 KMT2A (0.44) NPC1RAB9ASMN1; SMN2CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0629604-B1 Alicyclic phospholipase A2 inhibitors BRISTOL MYERS SQUIBB CO (US) 1997-04-16 EP disclosed
US-5436369-A Alicyclic phospholipase A2 inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 1995-07-25 US disclosed
EP-0629604-A2 Alicyclic phospholipase A2 inhibitors Bristol-Myers Company (US) 1994-12-21 EP disclosed